TMCnet News
Drug Discovery Technologies Market Intelligence Report for Comprehensive Information 2018-2024Our latest research report entitled Drug Discovery Technologies Market (by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies)) provides complete and deep insights into the market dynamics and growth of Drug Discovery Technologies. Latest information on market risks, industry chain structure Drug Discovery Technologies cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential Drug Discovery Technologies growth factors. The forecast Drug Discovery Technologies Market information is based on the present market situation, growth opportunities, development factors, and opinion of the industry experts. An in-depth analysis of the company profiles, Drug Discovery Technologies on global and regional level and applications is conducted. The analysis of downstream buyers, sales channel, raw materials, and industry verticals is offered in this report. According to report the global drug discovery technologies market is expected to grow at a CAGR of 18.4% over the forecast period of 2018 - 2024. Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/1128 The growing incidences of diseases, pathogen resistance to old drugs, patent expiries, and competition among drug manufacturers are the key factors that drive the growth of this market. Moreover, increasing investment in the field of nanotechnology, biotechnology, genomics, and, molecular biology are some other factor that has driven this market. Furthermore, long duration of drug discovery process, high initial setup cost and presence of strict regulatory surroundings. Segments Covered The report on global drug discovery technologies market covers segments such as technology type, and end users. The technology type segments include biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAI, combinatorial chemistry). On the basis of end users the global drug discovery technologies market is categorized into biopharmaceutical companies, pharmaceutical companies, research institutes and biotech companies. Geographic Coverage The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2016 – 2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018 - 2024. Ask Discount for the latest research report @ https://www.infiniumglobalresearch.com/reports/request-discount/1128 Major Key Players Mentioned in this Premium Report The report provides profiles of the companies in the global drug discovery technologies market such as, Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, and Astrazeneca plc. Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-drug-discovery-technologies-market As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments. |